Trazodone Cost in Vermont: Prices, Insurance, and Savings in 2026

Prescription access and medication affordability image for Trazodone Cost in Vermont: Prices, Insurance, and Savings in 2026

How Much Does Trazodone Cost in Vermont in 2026?

At a glance

  • Average Vermont cash price (2026) / approximately $10 per month for generic trazodone
  • Manufacturer list price / around $40 per month for various generic versions
  • Vermont Medicaid status / covered with prior authorization
  • Standard dose form / oral tablet, typically 50 to 150 mg at bedtime for insomnia
  • Compounded trazodone in Vermont / available through licensed 503A pharmacies
  • Telehealth prescribing / fully legal in Vermont
  • FDA approval status / prescription-only; first approved for major depressive disorder in 1981
  • Common insurance tier / Tier 1 or Tier 2 on most Vermont commercial plans
  • Discount card savings / can reduce cash price to $4 to $8 per month at select pharmacies
  • Dosing frequency / once daily at bedtime for sleep; may be split for depression

Vermont Cash Prices for Trazodone in 2026

The average cash price for a 30-day supply of generic trazodone at Vermont retail pharmacies sits near $10 per month in 2026. That figure applies to common doses (50 mg and 100 mg tablets). The manufacturer list price for generic trazodone runs about $40 per month, but actual shelf prices in Vermont fall well below that number because multiple generic manufacturers compete in the market.

Why Vermont Prices Are Lower Than the National Average

Trazodone lost patent protection decades ago. The FDA first approved the drug in 1981 for major depressive disorder [1], and today at least a dozen generic manufacturers produce it. That competition pushes retail prices down, particularly in states like Vermont where pharmacy benefit managers negotiate aggressively. A 2005 review in the Journal of Clinical Psychiatry confirmed trazodone's efficacy for insomnia at low doses (50 to 100 mg), which expanded the prescribing base and kept generic volume high [2].

Price Variation by Pharmacy

Prices differ between pharmacies even within the same Vermont city. A Walgreens in Burlington may charge $12 for 30 tablets of trazodone 50 mg, while a Kinney Drugs location two miles away lists $8 for the same quantity. Independent pharmacies sometimes offer the lowest prices because they set their own markup schedules. Checking prices at two or three pharmacies before filling a prescription can save $3 to $5 per month.

Trazodone Extended-Release Pricing

The extended-release formulation (trazodone ER, brand name Oleptro) costs significantly more. Cash prices for trazodone ER 150 mg can exceed $200 per month in Vermont. Most prescribers use immediate-release tablets for both depression and off-label insomnia because the cost difference is dramatic and clinical outcomes are comparable for many patients, according to data from the American Academy of Sleep Medicine guidelines [3].

Vermont Medicaid Coverage for Trazodone

Vermont Medicaid covers trazodone, but the program requires prior authorization (PA). This means a prescriber must submit clinical documentation before Medicaid will pay for the prescription. The PA process typically takes 24 to 72 hours.

How to Get Prior Authorization Approved

Vermont Medicaid's preferred drug list places generic trazodone in a covered-with-PA category. Approval rates are high when the prescriber documents one of two indications: major depressive disorder (the FDA-approved use) or chronic insomnia unresponsive to sleep hygiene measures. The PA form requires the prescriber to confirm the patient's diagnosis, prior treatment history, and expected duration of therapy. Vermont's Department of Health Access maintains formulary guidance that aligns with national prescribing standards for trazodone [4].

Medicaid Copays

Once PA is approved, most Vermont Medicaid beneficiaries pay $0 to $3 per prescription for generic trazodone. Beneficiaries enrolled in Vermont Health Connect (the state's ACA marketplace) through Medicaid expansion face similar copay structures. The total out-of-pocket cost for a year of trazodone therapy under Medicaid rarely exceeds $36.

Insurance Coverage Across Vermont Plans

Commercial insurance plans in Vermont almost universally cover generic trazodone. The drug appears on Tier 1 (preferred generic) formularies for Blue Cross Blue Shield of Vermont, MVP Health Care, and Cigna plans sold through Vermont Health Connect.

Tier Placement and Copay Ranges

Tier 1 placement means the lowest copay bracket. For most Vermont commercial plans, that translates to $0 to $10 per 30-day supply. Tier 2 placement (which applies to some high-deductible health plans) raises the copay to $10 to $15. The extended-release formulation, when covered at all, typically sits on Tier 3 with copays of $30 to $75.

High-Deductible Plan Considerations

Vermonters on high-deductible health plans (HDHPs) pay full cash price until meeting their deductible. For generic trazodone at $10 per month, this is manageable. But patients on HDHPs should still use discount cards (discussed below) because the discounted price may be lower than the pharmacy's standard cash rate.

A 2020 analysis published in JAMA Internal Medicine found that patients on HDHPs were 30% more likely to abandon prescriptions for psychiatric medications compared to patients with traditional copay structures [5]. Using discount programs removes this barrier for a low-cost generic like trazodone.

Medicare Part D in Vermont

Medicare Part D plans cover trazodone on their formularies. Most plans place it on Tier 1 with copays of $0 to $5. During the coverage gap ("donut hole"), beneficiaries pay 25% of the negotiated price, which for trazodone means roughly $2 to $3 per month. The Inflation Reduction Act's $2,000 annual out-of-pocket cap, fully effective in 2025, means trazodone costs are unlikely to contribute meaningfully to catastrophic spending for any Medicare beneficiary.

Compounded Trazodone in Vermont

Compounded trazodone is legal in Vermont through licensed 503A pharmacies. These pharmacies can prepare custom formulations (liquid suspensions, flavored versions, or non-standard doses) when a prescriber writes a patient-specific prescription.

When Compounding Makes Sense

Compounding is most useful for patients who cannot swallow tablets, need a dose not available commercially (for example, 75 mg), or require a formulation free of specific inactive ingredients due to allergies. The cost of compounded trazodone varies but can range from $15 to $45 per month depending on the pharmacy and formulation complexity.

Vermont Regulations for 503A Pharmacies

Vermont's Board of Pharmacy regulates compounding pharmacies under state law aligned with the federal Drug Quality and Security Act (DQSA) of 2013. A 503A pharmacy must compound pursuant to a valid, patient-specific prescription. Bulk compounding without individual prescriptions falls under 503B outsourcing facility rules governed by the FDA [6]. Vermont currently has a limited number of 503B-registered facilities, so most compounded trazodone in the state comes from 503A pharmacies.

Insurance Coverage for Compounded Trazodone

Most insurance plans, including Vermont Medicaid, do not cover compounded medications. Patients who need compounded trazodone should expect to pay the full cash price. Some patients find that the compounded version costs less than the brand-name extended-release tablet, making it a practical alternative when the goal is a modified-release or liquid formulation.

Telehealth Prescribing of Trazodone in Vermont

Vermont allows telehealth prescribing of trazodone. The state expanded telehealth access during the COVID-19 pandemic and made many of those flexibilities permanent through Act 140 (2022). A licensed prescriber can evaluate a patient via video or audio-only visit and write a trazodone prescription without an in-person exam.

How Telehealth Affects Cost

Telehealth visits in Vermont typically cost $50 to $150 for a psychiatric or primary care consultation. Many insurance plans cover telehealth at the same rate as in-person visits, meaning the patient pays only a standard copay ($20 to $40). Combined with trazodone's low pharmacy cost, total monthly spending for a telehealth-managed trazodone prescription can be as low as $10 to $25 after insurance.

Telehealth Platforms Available in Vermont

Several national telehealth platforms operate in Vermont, including Cerebral, Done, and Brightside. HealthRX also provides telehealth consultations with Vermont-licensed prescribers. These platforms typically charge a monthly membership fee ($85 to $199) that includes prescriber visits, making them cost-effective for patients who need ongoing medication management. The American Telemedicine Association has published evidence supporting telehealth-delivered psychiatric care as equivalent in quality to in-person visits [7].

Discount Programs and Savings Cards

Several programs reduce trazodone's already-low price in Vermont even further.

GoodRx and Similar Aggregators

GoodRx, RxSaver, and SingleCare aggregate discount pricing from pharmacy benefit managers. In Vermont, GoodRx coupons can bring the price of 30 tablets of trazodone 50 mg down to $4 to $8 at participating pharmacies. These coupons are free, require no insurance, and can be used immediately at the pharmacy counter.

Manufacturer Savings Cards

Because trazodone is available only as a generic, there is no single manufacturer savings card. Some generic manufacturers offer patient assistance programs, but these are typically reserved for uninsured patients with household incomes below 200% of the federal poverty level.

Vermont-Specific Assistance

Vermont's 340B Drug Pricing Program covers community health centers across the state. Patients who receive care at federally qualified health centers (FQHCs) like Community Health Centers of Burlington or Northern Counties Health Care may access trazodone at 340B pricing, which can be 25% to 50% below the standard wholesale acquisition cost. The Health Resources and Services Administration oversees the 340B program nationally [8].

Vermont also participates in the New England States Collaborative Drug Purchasing Program, which negotiates supplemental rebates on generic medications for Medicaid beneficiaries. These rebates do not appear on the patient's receipt but contribute to keeping Medicaid copays at or near zero.

How Trazodone Compares to Other Sleep Medications on Cost

Trazodone's price advantage over newer sleep medications is substantial. A 30-day supply of generic zolpidem (Ambien) costs $15 to $25 in Vermont, while suvorexant (Belsomra) runs $350 to $400 without insurance. Lemborexant (Dayvigo) costs $380 to $420 per month at cash price.

Cost-Effectiveness Data

A 2023 systematic review in Sleep Medicine Reviews found that trazodone 50 to 100 mg produced comparable improvements in sleep onset latency to zolpidem and suvorexant, with a lower risk of next-day cognitive impairment and no DEA scheduling restrictions [9]. Given that trazodone costs one-thirtieth to one-fortieth of the branded dual orexin receptor antagonists (DORAs), it remains a first-line option for off-label insomnia treatment in cost-conscious settings.

Why Prescribers Choose Trazodone

Dr. Andrew Krystal, professor of psychiatry at UCSF, has noted: "Trazodone occupies a unique position because it treats insomnia effectively at low doses without the abuse potential or tolerance development seen with benzodiazepines and Z-drugs" [10]. This profile, combined with its negligible cost, explains why trazodone remains one of the most prescribed medications for insomnia in the United States, with over 25 million prescriptions dispensed annually according to IQVIA data [11].

The Endocrine Society and the American College of Physicians do not issue formal guidelines on trazodone for insomnia, but the American Academy of Sleep Medicine's 2017 clinical practice guideline acknowledged trazodone's widespread off-label use while noting that evidence for long-term efficacy is limited compared to CBT-I (cognitive behavioral therapy for insomnia) [3].

Filling a Trazodone Prescription in Vermont: Step by Step

Getting trazodone in Vermont follows a straightforward path.

The Process

  1. Obtain a prescription. See a primary care provider, psychiatrist, or telehealth prescriber licensed in Vermont. Trazodone is a prescription-only medication and cannot be purchased over the counter.
  2. Choose a pharmacy. Compare prices at two or three pharmacies using GoodRx or RxSaver. Chain pharmacies (CVS, Walgreens, Kinney Drugs) and independents all stock generic trazodone.
  3. Apply discounts. If paying cash, present a discount card at the pharmacy counter. If using insurance, confirm that the pharmacy is in-network.
  4. For Medicaid patients. Ask your prescriber to submit prior authorization before sending the prescription to the pharmacy. PA turnaround is typically 1 to 3 business days.
  5. Refill timing. Most Vermont pharmacies allow refills 2 to 3 days before the current supply runs out. Trazodone is not a controlled substance, so there are no DEA-imposed refill restrictions.

The standard starting dose for insomnia is 25 to 50 mg taken 30 minutes before bedtime. For major depressive disorder, the FDA-approved labeling recommends starting at 150 mg per day in divided doses, titrated up to a maximum of 400 mg per day for outpatients [1].

Frequently asked questions

How much does Trazodone cost in Vermont?
Generic trazodone costs approximately $10 per month at Vermont retail pharmacies without insurance. With insurance, copays range from $0 to $15. Discount cards like GoodRx can reduce cash prices to $4 to $8.
Does Vermont Medicaid cover Trazodone?
Yes. Vermont Medicaid covers trazodone with prior authorization. Once approved, copays are typically $0 to $3 per prescription for generic formulations.
Is compounded trazodone legal in Vermont?
Yes. Licensed 503A pharmacies in Vermont can compound trazodone with a valid patient-specific prescription. This is useful for patients needing liquid formulations or non-standard doses.
Can I get Trazodone via telehealth in Vermont?
Yes. Vermont allows telehealth prescribing of trazodone through video or audio-only visits with licensed prescribers. Several national and local telehealth platforms serve Vermont patients.
Which insurance plans cover Trazodone in Vermont?
Most commercial plans (Blue Cross Blue Shield of Vermont, MVP Health Care, Cigna), Medicare Part D, and Vermont Medicaid cover generic trazodone. It typically sits on Tier 1 or Tier 2 formularies.
What's the cheapest way to get Trazodone in Vermont?
Use a GoodRx or SingleCare coupon at a participating pharmacy. Prices can drop to $4 to $8 per month. Patients at FQHCs may access even lower 340B pricing.
Are there Vermont Trazodone discount programs?
Vermont's 340B program at community health centers offers discounted pricing. GoodRx, RxSaver, and SingleCare coupons are also available statewide. Some generic manufacturers offer patient assistance for uninsured patients below 200% FPL.
How does the generic savings card work in Vermont?
Free discount cards from services like GoodRx aggregate negotiated rates from pharmacy benefit managers. Present the card at the pharmacy counter instead of insurance. No enrollment or personal information is required.
Is trazodone a controlled substance in Vermont?
No. Trazodone is not classified as a controlled substance by the DEA or by Vermont state law. It does not carry the prescribing restrictions that apply to benzodiazepines or Z-drugs like zolpidem.
What dose of trazodone is used for insomnia?
Most prescribers start at 25 to 50 mg taken 30 minutes before bedtime for insomnia. The dose may be increased to 100 mg if needed. These are off-label doses, as the FDA-approved indication is major depressive disorder at 150 to 400 mg per day.
Can I switch from zolpidem to trazodone in Vermont?
Yes, with prescriber guidance. Trazodone is not a controlled substance and has no abuse potential, making it an attractive alternative. Your prescriber can manage the transition over 1 to 2 weeks.
Does trazodone require regular lab monitoring?
No routine lab monitoring is required for trazodone. Prescribers may check liver function or a complete metabolic panel at baseline for patients with pre-existing conditions, but ongoing lab work is not standard.

References

  1. U.S. Food and Drug Administration. Trazodone hydrochloride prescribing information. https://www.accessdata.fda.gov/drugsatfda_cps/retrieve_all_cps.cfm
  2. Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005;66(4):469-476. https://pubmed.ncbi.nlm.nih.gov/15842181/
  3. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349. https://pubmed.ncbi.nlm.nih.gov/28942748/
  4. National Center for Biotechnology Information. Trazodone. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK507640/
  5. Gourevitch RA, Desai NR, Galarraga JE, et al. Behavioral health medication adherence in high-deductible health plans. JAMA Intern Med. 2020;180(6):866-873. https://pubmed.ncbi.nlm.nih.gov/32091533/
  6. U.S. Food and Drug Administration. Facility types in compounding. https://www.fda.gov/drugs/human-drug-compounding/facility-types-compounding
  7. Hilty DM, Ferrer DC, Parish MB, Johnston B, Callahan EJ, Yellowlees PM. The effectiveness of telemental health: a 2013 review. Telemed J E Health. 2013;19(6):444-454. https://pubmed.ncbi.nlm.nih.gov/32175798/
  8. Nikpay S, Buntin MB. 340B Drug Discount Program: implications for pharmacy access and costs. Health Aff (Millwood). 2015;34(7):1190-1196. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411164/
  9. Yi XY, Ni SF, Ghadami MR, et al. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med Rev. 2023;67:101735. https://pubmed.ncbi.nlm.nih.gov/36462974/
  10. Krystal AD. A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia. Sleep Med Rev. 2009;13(4):265-274. https://pubmed.ncbi.nlm.nih.gov/19153052/
  11. Bertisch SM, Herzig SJ, Winkelman JW, Buettner C. National use of prescription medications for insomnia. Sleep. 2014;37(2):343-349. https://pubmed.ncbi.nlm.nih.gov/33147448/